An Act to amend the Controlled Drugs and Substances Act (supervised drug consumption sites)
Protecting children’s safety is essential, but a rigid, one-size-fits-all buffer that overrides ministerial discretion risks service disruption, higher costs, and potential public safety setbacks if consumption is displaced to streets near schools. The bill conflicts with reducing red tape and government efficiency, with unclear benefits for prosperity or competitiveness.
What evidence supports a nationwide 500‑metre threshold versus alternative, risk-based distances, and how many existing sites by city would be forced to close or move under this bill?
What is the projected impact on overdoses, emergency room usage, and policing costs during the 180‑day transition, and who bears the relocation costs for affected sites?
Will the government amend the bill to allow case-by-case discretion where sites have strong safety records and community safety plans, and how exactly will the 500‑metre distance be measured and enforced to avoid legal disputes?
The siting rule targets public safety around schools but has indirect and uncertain effects on overall prosperity.
Imposes a rigid statutory constraint and removes ministerial discretion, likely increasing compliance burdens and limiting local flexibility.
Any productivity effects via public health or community safety are indirect and unclear.
No bearing on trade or exports.
Primarily a public health siting rule; limited relevance to investment or resource development.
Revoking and relocating sites within six months may raise administrative, policing, and health-system costs while reducing operational flexibility.
No tax measures are affected.
A narrow siting prohibition does not materially contribute to large-scale prosperity.
Did we get the builder vote wrong?
Email hi@buildcanada.com